Shvabe Holding and St. Petersburg and Peter the Great St. Petersburg Polytechnic University (SPbPU) are working together to create the first Russian complex for non-invasive neoplasm therapy. Production of a new system for HIFU-therapy will be organized at the facilities of the Novosibirsk Instrument-Making Plant. Pilot samples are planned to be created by the end of 2019.
The hardware-software complex for HIFU-therapy is intended for diagnosing and treating breast neoplasms using high-intensity focused ultrasonic radiation.
At the present moment, preparation of technical project has been completed, and the specialists have started the development of design documentation with methods for the complex application. A prototype of the product is planned to be created by the end of 2019, and in 2020 it will already be possible to conduct clinical trials, after which the company will be able to obtain a registration certificate for a new device and commence mass production.
“Non-invasive therapy is one of the safest ways to treat oncological diseases. The domestic complex of HIFU-therapy has a number of advantages in comparison with its foreign analogues: it is more compact, it is much easier to maintain.
Other advantages include possibility of electronic guidance and continuous monitoring of radiation effect on neoplasm. The complex, first off, will be supplied to Russian consumers. The potential of the device allows to take up to 90 percent of this market. We are confident that the device will be in demand abroad as well”, commented Oleg Evtushenko, Rostec's executive director.
In future, a whole line of devices on the basis of the complex, with similar functional effects might be created for therapy of neoplasms and tumors of liver, prostate gland and brain.